“Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy: the SIMPL’HIV open-label, factorial randomised controlled trial”, Swiss Med Wkly, vol. 154, no. 4, p. 3762, Apr. 2024, doi: 10.57187/s.3762.